Background/Aims: Aberrantly high levels of H3K4me3, caused by incomplete epigenetic reprogramming, likely cause a low efficiency of somatic cell nuclear transfer (SCNT). Smal molecule inhibitors aimed at epigenetic modification can be used to improve porcine SCNT embryo development. In this study, we examined the effects of MM-102, an H3K4 histone methyltransferase inhibitor, on porcine SCNT preimplantation embryos to investigate the mechanism by which H3K4 methylation regulated global epigenetic reprograming during SCNT. Methods: MM-102 was added to the SCNT embryos culture system and the global levels of various epigenetic modifications were measured by immunofluorescence (IF) staining and were quantified by Image J software. Relative genes expression levels were detected by quantitative real-time PCR. Results: MM-102 (75 μM) treatment reduced global H3K4, H3K9 methylation and 5mC levels especially at the zygotic gene activation (ZGA) and blastocyst stages. MM-102 treatment mainly down-regulated a series of DNA and histone methyltransferases, and upregulated a number of hitone acetyltransferases and transcriptional activators. Furthermore, MM-102 treatment positively regulated the mRNA expression of genes related to pluripotency (OCT4, NANOG, CDX2) and apoptosis (BCL2). Conclusion: Down-regulation of H3K4me3 with MM-102 rescued aberrant gene expression patterns of a series of epigenetic chromatin modification enzymes, pluripotent and apoptotic genes at the ZGA and blastocyst stages, thereby greatly improving porcine SCNT efficiency and blastocyst quality, making them more similar to in vivo embryos (IVV).
Introduction
Somatic cells which are terminally differentiated can be reprogrammed to the totipotent state through somatic cell nuclear transfer (SCNT) [1] . SCNT holds great potential for animal husbandry, regenerative medicine and the conservation of endangered animals [2] . Moreover, embryonic stem cells derived from SCNT blastocysts (ntESCs) are a valuable cell type for gene editing, studying animal disease model, and investigating cell/tissuereplacement therapies. The pig is a promising animal model in therapeutic and biomedical research, such as bioreactor and xenotransplantation. However, studies of these potential applications progress slowly in pigs, because the cloning efficiency is extremely low and no authentic porcine ntESCs are currently available [3] [4] [5] [6] .
The first developmental arrest of SCNT embryos is believed to generally occur at the same time as zygotic genome activation (ZGA), which occurs at the 2-cell stage in mice, at the 4-cell stage in pigs, at the 8-cell stage in human and at the 16-cell stage in cattle [7] . Incomplete ZGA is largely caused by certain key epigenetic barriers [8] . Histone modifications play crucial roles in regulating the expression of zygotic genes [9, 10] and are highly dynamic, with extensive changes during mammalian preimplantation embryo development [11, 12] . The down-regulation of H3K9me3 and H3K4me3 could improve transcriptional reprogramming of mouse SCNT preimplantation embryos and the production of cloned descendants [13] . H3K9 and H3K4 methylation also show abnormal expression levels in porcine SCNT embryos [14] . The down-regulation of H3K9 methylation by BIX-01294 could improve epigenetic reprogramming of porcine SCNT embryos [15] , but there have been very few studies about whether the down-regulation of H3K4 methylation can play a similar role during porcine SCNT embryo development.
KMT2A, also known as mixed-lineage leukaemia 1 (MLL1), is a specific H3K4 methyltransferase (HMT) [16] . MM-102 is a high-affinity small molecule inhibitor that can efficiently inhibit H3K4 HMT activity of the MLL1 core complex through breaking the protein-protein interaction of the MLL1 core complex [17] . However, the effect of MM-102 on SCNT reprogramming has not been reported.
This study was conducted to determine the effects of MM-102 treatment on the global expression patterns of epigenetic modification enzymes and genes related to pluripotency and apoptosis at different stages. Our study will offer an effective way to identify whether abnormal H3K4 methylation is a major epigenetic barrier for ZGA, and reveal crucial epigenetic factors responsible for reprogramming during porcine SCNT embryos development.
Materials and Methods

Chemicals and animals
All animal treatments were conducted in accordance with the experimental procedures and standards approved by the Animal Welfare Research Ethics Committee of Jilin University. (Approval ID:20151008-1). MM-102 was purchased from Selleck Chemicals (Houston, TX, USA). Other chemicals were purchased from Sigma-Aldrich (St. Louis, MO, USA), unless otherwise stated.
Collection and in vitro maturation of porcine oocytes
Porcine ovaries were collected from a local abattoir and transported to the laboratory. The ovaries were kept in 0.9% NaCl supplemented with 200 IU/mL penicillin and streptomycin at 35-36.5 °C. The follicular fluid containing cumulus-oocyte complexes (COCs) from 3-6 mm ovarian follicles was aspirated using an 18-gauge needle. COCs with at least three layers of cumulus cells were selected, washed three times in manipulation fluid (TCM-199 supplemented with 0.1% polyvinyl alcohol), and then cultured in in vitro maturation (IVM) media [18] . Approximately 30 COCs were each cultured in a 100 μL drop of maturation medium (TCM-199 supplemented with 10 µg/mL epidermal growth factor, 0.5 μg/mL porcine luteinizing hormone, 0.5 μg/mL porcine follicle-stimulating hormone, 26 mM sodium bicarbonate, 3.05 mM glucose, 0.91 mM sodium pyruvate, 0.57 mM cysteine, 0.1% PVA, 10% foetal calf serum, 75 mg/mL penicillin G and 50 mg/mL streptomycin) for 22-24 h and then cultured with hormone-free maturation medium (TCM-199 supplemented with 26 mM sodium bicarbonate, 3.05 mM glucose, 0.91 mM sodium pyruvate, 0.57 mM cysteine, 10 µg/ml epidermal growth factor, 0.1% (w/v) PVA, 0.03% (w/v) BSA, and 100 µl/mL penicillin/streptomycin) for 20 h at 38.5 °C and 5% CO 2 . Then, cumulus cells were removed from oocytes with manipulation fluid supplemented with 0.2% hyaluronidase. The oocytes with polar body 1 (PB1) were considered matured and used for the following experiments.
In vitro fertilization (IVF)
Fresh semens purchased from the Jilin University pig farm was washed three times with DPBS containing 0.1% BSA and centrifuged at 1000 rpm for 5 minutes, then the supernatant was removed. The sperm were resuspended with fertilization medium (mTBM [19] ) containing 2 mg/ml BSA and 2 mM caffeine, and then were cultured for 30 min. Twenty-five denuded matured oocytes were each cultured in 100 μl of fertilization medium containing diluted spermatozoa, with a final sperm concentration of 1.6×10 5 -5.0×10
5 sperm/ml, at 38.5 °C and 5% CO 2 for 6 hours. After washing off the adherent sperm, the fertilized oocytes were transferred to PZM-3 [20] .
Somatic cell nuclear transfer
The first polar body of denuded matured oocytes was removed with a bevelled pipette in the manipulation fluid supplemented with 7.5 mg/mL cytochalasin B. Porcine embryo fibroblasts (PEFs) obtained from 35-day-old foetuses of Large White pigs were used as donor cells (3rd to 7th passage) for SCNT. After cultured in porcine zygote medium 3 (PZM3) for 1 h, the reconstructed embryos were activated in fusion medium (0.28 M mannitol, 0.1 mM MgSO 4 , and 1 mM CaCl 2 ) using an electro-fusion instrument (ECM2001, BTX). The activation parameter was set as two successive DC pulses at 1.2 kV/cm for 30 μs. Fused embryos were cultured in PZM-3 medium with or without MM-102 at 38.5 °C and 5% CO 2 .
MM-102 treatment and embryo culture MM-102 was diluted with aseptic ultrapure water to 20 mM and stored in small aliquots at -80 °C. After electric activation, the fused embryos were treated with different concentrations (0-100 μM) of MM-102 for gradient duration (0-96 h). The 2-cell cleavage and blastocyst rates were determined at 48 h and 7 days after culturing respectively.
RNA isolation and quantitative PCR (qPCR)
Total RNA was extracted from porcine oocytes and SCNT embryos by AllPrep DNA/RNA Micro Kit (Qiagen). cDNA was synthesized using TransScript All-in-One First-Strand cDNA Synthesis SuperMix for qPCR (TranGen Biotech). The primers used for qPCR are listed in Table 1 . SYBR ® Premix Ex TaqTM reagents (TaKaRa) were used for qPCR. The reaction system of qPCR was as follows: 10 µl of SYBR green premix, 1 µl of each forward and reverse primer (10 µM), 1 µl of cDNA and 7 µl of ddH 2 O. The reaction protocol was as follows: 30 s initial denaturation at 95 °C, followed by 45 cycles of two steps (95 °C for 5 s and 60 °C for 30 s) and cooling at 4 °C. The relative expression of each gene was analysed using the 2 -∆∆CT method. GAPDH was used as the reference gene.
RT² profiler PCR array
The Pig Epigenetic Chromatin Modification Enzymes RT² Profiler PCR Array (Qiagen, PASS-085Z) was performed according to the manufacturer's instructions. The detected genes can be found on the official website of Qiagen. Quality control was confirmed using GeneGlobe Data Analysis Center (Qiagen). The results only included data that passed quality checks. The standards for significant differences are at least 2-fold change and p < 0.05. [21] . The relative expression values of each tested gene was provided as △△CT value to evaluate the transcript level. The significantly differentially expressed genes were assessed using the LIMMA package integrated in the Degust pubulic server. The heat maps showing the genic relationship matrices were created in R studio Version 1.1.383 [22] with the Heatmaply package [23] . The complete linkage hierarchical clustering was performed by the Euclidean distance measure.
Immunofluorescence (IF) staining
All operations were carried out at room temperature, unless otherwise specified. Embryos were washed with PBS containing 0.1% polyvinylpyrrolidone. The zona pellucida (ZP) of embryos was dissolved by acidic Tyrode solution (pH 2.5). After a wash in PBS-PVP, embryos were fixed with 4% paraformaldehyde for 30 min in the dark. After being washed in PBS-PVP, embryos were permeabilized with 0.1% Triton X-100/PBS (v/v) for 20 min and then blocked with 2% BSA/PBS for 1 h. Embryos were incubated overnight at 4 °C with primary antibodies targeting 5mC and 5hmC (Eurogentec; diluted 1:200); H3K4me2/3 (Abcam; diluted 1:200); and H3K9me3 (Abcam; diluted 1:200). After being washed in PBS-PVP, embryos were stained with Alexa Fluor 488 goat anti-rabbit (Invitrogen; diluted 1:200) and / or Alexa Fluor 488 goat antimouse (Invitrogen; diluted 1:200) at 37 °C for 2 h. DNA was stained with 10 μg/mL DAPI for 10 min. For 5mC/5hmC staining, there were two additional treatments between permeabilization and block: embryos were treated with 4N HCl for 30 min and then with Tris-HCl buffer (100 mM, pH 8.5). All samples were observed under a Nikon Eclipse Ti-U microscope equipped with appropriate filters (Nikon, Tokyo, Japan) after mounting. Colour images were captured using a DS-Ri2 CCD camera (Nikon, Tokyo, Japan) and an analysis software (NIS-Elements BR; Nikon, Tokyo, Japan). Separate images for DAPI and FITC staining were captured digitally from double stained embryos and separated into their single colour components (blue for DAPI and green for 5mC and red for 5hmC, H3K4me3, H3K4me2 and H3K9me3). The same exposure times and microscope settings were used for all captured images. Each experiment was biologically replicated at least 5 times. The analysis of fluorescence intensity was analysed using Image J software (National Institutes of Health, Bethesda, MD) based on the procedures described elsewhere [24] [25] [26] . The cytoplasmic background fluorescence intensity was measured as an average intensity level within the cytoplasmic area. Thereafter, the correction for the cytoplasmic background was carried out and the background-subtracted images were used for further analysis. The FITC labeling intensity in nucleus of porcine embryos were calculated as the FITC fluorescence intensity. For the semi-quantification of fluorescence intensity, the average DAPI intensity from nucleus of embryos was set as 100% and the FITC labeling intensity of each nucleus was compared to it.
Apoptosis assays on the blastocysts
The steps before permeabilization referred to IF staining. After permeabilization, embryos were incubated with TUNEL solution (In Situ Cell Death Detection Kit, Roche; Mannheim, Germany) in the dark for 1 h at 37 °C. Embryos incubated only with fluorescein-conjugated dUTP were the negative control. Embryos pre-treated with DNAses for 10 min at 15-25 °C were the positive control. Then, embryos were washed three times with PBS-PVA. Nuclei were stained with DAPI for 10 min. All samples were observed under a fluorescence microscope (Nikon, Tokyo, Japan) after mounting. Each experiment was biologically replicated at least 5 times. The same exposure times and microscope settings were used for all captured images.
Statistical analysis
Each experiment was biologically replicated at least three times. The statistical analysis was conducted by one-way ANOVA using Statistics Production for Service Solution (SPSS) 19.0 software (Chicago, IL, USA). The statistically standards of significance or extremely significance was considered at P-value <0.05 or <0.01, respectively. Fig. 1A and 1B) . IF signal intensity of H3K4me3 in SCNT embryos was very strong from the 2-cell to the 4-cell stage, and gradually decreased until the 8-cell stage, followed by a significant increase at the blastocyst stage. Compared with IVF 4-cell (IVF-4C) embryos, the signal intensity of H3K4me3 in SCNT 4-cell (NT-4C) embryos was significantly higher (p < 0.05).
Then, we chose MM-102, a small-molecule inhibitor of MLL-1, to downregulate the abnormally high level of H3K4 methylation in porcine SCNT embryos. The experimental groups were treated with 50 μM, 75 μM and 100 μM MM-102 for 48 h, and the control group was treated with 0 μM MM-102. The concentration gradient of MM-102 causes differences in the development rates of NT embryos (Fig. 1C ) (Table 2). The 2-cell cleavage rates (48 h after activation) of SCNT embryos treated with 50 μM (72.4 ± 8.1) or 75 μM MM-102 (73.3 ± 6.3) were not significantly higher than those of the control group (70.6 ± 5.2), but treatment with 100 μM MM-102 markedly decreased the cleavage rate (35.3 ± 4.5). The experimental groups treated with 50 μM or 75 μM MM-102 had higher 4-cell (52.1 ± 2.6 and 65.0 ± 6.3, respectively) and 8-cell (22.3 ± 1.6 and 40.0 ± 3.4, respectively) cleavage rates compared with 100 μM MM-102 (22.3 ± 1.5 and 10.0 ± 0.8) and control group (39.2 ± 2.1 and 15.2 ± 3.1). Consistent with this finding, the experimental groups treated with 50 μM (12.1 ± 1.0) or 75 μM MM-102 (21.9 ± 1.6) had higher blastocyst rates than the 100μM MM-102 (2.0 ± 0.6) and control groups (9.7 ± 0.3). Additionally, the total cell numbers of blastocysts (45.3 ± 1.5) in 75 µM MM-102 group showed a distinct advantage among all groups. Then, porcine SCNT embryos were treated with 75 µM MM-102 for 0, 24, 48, 72 and 96 h (Table 3) . No difference was seen in the cleavage 
MM-102 treatment rescued abnormal epigenetic reprogramming in porcine SCNT embryos
We next sought to study how MM-102 affected global abnormal expression profiles of epigenetic modification enzymes that might rescue incomplete ZGA and low developmental efficiency of porcine SCNT embryos. We performed a pig epigenetic chromatin modification enzymes RT² Profiler PCR Array in 4-cell NT embryos treated with/ without MM-102 (MM102-4C), and IVV embryos were used as the control. According to analytical results, we identified numerous epigenetic modification enzymes that showed abnormal expression profiles in SCNT embryos compared with those in IVV embryos( Fig.  2A and 2C ). However, these abnormal genes were partially rescued after MM-102 treatment, and their global expression patterns were more similar to those of IVV-4C embryos ( Fig. 2A and  2C ). There were 16 genes whose abnormal expression profiles in NT-4C embryos were obviously rescued by MM-102 (Fig. 2E) . We also performed PCR arrays in blastocysts derived from IVV, SCNT and MM102-NT. The global expression pat- terns of epigenetic modification enzymes in IVV-Bla and NT-Bla were almost completely opposite ( Fig. 2B and 2D ). However after MM-102 treatment, compared with NT-Bla, the great majority of abnormally expressed genes were rescued, and their expression patterns were more similar between IVV-Bla and MM102-Bla ( Fig. 2B and 2D) . We further detected several kinds of crucial epigenetic modifications of MM102-NT embryos, which were closely associated with ZGA at protein level by IF staining, such as H3K4me2/3, H3K9me3 and 5mC/5hmC. The results showed that each modification had its own special dynamic change characteristic. For H3K4me3, compared with IVF counterparts at 4-cell and blastocyst stages, MM-102 treatment significantly decreased the abnormally high expression level in NT-embryos, while was the exception at the 2-cell and 8-cell stages (Fig. 3A and 3C ). For H3K4me2, the expression levels in MM102-NT embryos were between those in IVF and NT embryos at the 2-cell and 4-cell stages and were significantly lower at the 8-cell stage, but there were no obvious differences at the blastocyst stage among the three groups ( Fig. 3B and 3D ). For H3K9me3, compared with IVF counterparts at 4-cell and blastocyst stages, MM-102 treatment also significantly decreased the abnormally high expression level in NT-embryos, but there were no significant differences at the 2-cell and 8-cell stages (Fig. 4A and 4C ). For 5mC, the expression levels in MM102-NT embryos were always between those in IVF and NT embryos from the 2-cell and 8-cell stages, while there were no obvious differences at the blastocyst stage ( Fig. 4B  and 4D ). For 5hmc, the overall trend of each group was on the rise during preimplantation development, and the expression levels in MM102-NT embryos were always between those in IVF and NT embryos, except for at the 2-cell stage (Fig. 4B and 4E ).
MM-102 treatment improved genes expression pattern which were critical to the development of SCNT embryos
We detected mRNA expression profiles of pluripotency-related genes (POU5F1 and NANOG) and apoptosis-related genes (BCL2 and BAX) at different stages derived from IVV, SCNT and MM102-NT embryos. We found that compared with SCNT embryos, the expression of POU5F1, NANOG and BCL2 was significantly higher in MM102-NT embryos throughout the developmental process (Fig. 5A-5C ). Particularly, NANOG significantly increased 2-fold, and the expression of POU5F1 significantly increased 11-fold at the 4-cell stage. The expression of BAX in NT embryos was significantly decreased after MM-102 treatment at whole developmental stages (Fig. 5D) . The blastocysts derived from the IVF (60.12 ± 3.4) and MM102-NT (45.3 ± 1.5) had higher total cell number than SCNT (36.6 ± 0.88) blastocysts. Apoptotic staining showed that the percentage of apoptotic cells in the MM102-NT blastocysts was significantly lower than that in the SCNT blastocysts (20.1 ± 1.5, 28.6 ± 3.2, respectively) but higher than that in the IVF blastocysts (15.7 ± 2.6) ( Fig. 5E and 5F ). 
Discussion
People have endeavoured on somatic cell nuclear transfer for more than 50 years [1] , but the cloning efficiency of most animal species is still very low. The underlying mechanisms that contribute to SCNT efficiency remain unknown. Incomplete ZGA led to poor developmental potential of mouse and human SCNT embryos [12, 27] . The critical barrier of incomplete ZGA is epigenetic modifications such as H3K9 and H3K4 methylation, that pre-exist in donor cell genome [12, 13, 27] . H3K4me3 was confirmed as a barrier for mouse SCNT 4-cell arrest, and the down-regulation of H3K4me3 level by over-expression of the H3K4 demethylase KDM5B could promote mouse 4-cell SCNT embryos development [28] . The ZGA of porcine fertilized embryos occurs at the 4-cell stage and is delayed in SCNT embryos [29] , and H3K4me3 levels in porcine 4-cell SCNT embryos were confirmed to be abnormally higher than those in IVF embryos by IF staining [14] , but the study on how abnormally high H3K4me3 affects ZGA and the development of porcine SCNT embryos, still has not yet been reported. H3K4 methylation is regulated by specific methyltransferases and demethylases. KMT2A, known as mixed-lineage leukaemia 1 (MLL1), is a H3K4 methyltransferase, and its catalytic activity is tightly controlled and greatly enhanced by a MLL1 core complex [30, 31] . MM-102 prevents the interaction of the MLL1 core complex and function as an MLL1 inhibitor [17] . MM-102 is usually used in leukaemia studies, and its role in promoting SCNT reprogramming has not been reported. Previous researchers have studied the effect of inhibitors aiming at one or several epigenetic modification; for example, TSA and BIX-01294 co-treatment significantly down-regulated 5mC and H3K9me2 levels in porcine SCNT embryos [32] . It is worth noting that these epigenetic modifications often act in a context-dependent manner to facilitate or repress chromatin-mediated processes and could influence one another, such that one modification recruits or activates chromatin-modifying complexes to generate a different modification [33] . It is a pity that few studies have focused on global epigenetic modifications, especially during porcine SCNT embryo development.
Direct measurements of chromatin states are hindered by technical difficulties in small quantities of cells, especially early embryos. Cao et al. characterized and compared global dynamic patterns of 12 different histone methylation modifications during porcine SCNT reprogramming by IF staining [14] , but no comprehensive analysis has been performed on dynamic mRNA profiling of global epigenetic modification enzymes during porcine SCNT preimplantation embryo development. A previous study suggested that abnormally high mRNA expression of DNMT1/3A would cause either embryonic apoptosis or incomplete reprogramming in porcine cloned embryos [34] , but no analysis of DNMT3B was shown. Zhou et al. found that H3K27ac was defective in porcine late SCNT blastocysts whose dynamic change was well correlated with the gene expression of HDAC1 and HDAC2, which might underlie the barrier of ZGA [35] , but the roles of other HDAC family members or histone acetyltransferases were not studied at the same time. In our study, we conducted an overall analysis of mRNA expression profiles of 84 representative epigenetic modification enzymes; those related to DNA methylation (3 kinds), histone methylation (37 kinds), acetylation (31 kinds), phosphorylation (16 kinds) and ubiquitylation (9 kinds) by means of an RT² profiler PCR array for the first time. We detected that compared with IVV-4C embryos, there were 39 enzymes (up -21, down -18) expressed at significantly different levels in SCNT-4C embryos. Most of these 21 up-regulated genes were related to gene transcription silencing, such as multiple DNA methyltransferases(DNMT1/3A/3B) and histone methyltransferases (9 kinds). The significant up-regulation of these genes was bound to block ZGA. Therefore, we deduced that the abnormal up-regulation of these genes played a crucial role in arresting ZGA during SCNT. Among these 18 down-regulated genes, two classes of genes possessed histone acetyltransferase activity (8 kinds), and their aberrant down-regulation would inevitably cause transcriptional repression of zygotic genes. Our results suggested that porcine SCNT-4C embryos had a global aberrant expression profile of chromatin modification enzymes, and we deduced that this finding was the key cause of the ZGA barrier and incomplete reprogramming. MM-102 treatment caused the down-regulation of H3K4 methylation in SCNT embryos. Although MM102 targeted H3K4 methylation, it amazed us that the affected epigenetic chromatin modification enzymes were not confined to histone methylation, but invovled in almost global epigenetic modifications. We found that abnormal expression profiles of the majority of epigenetic modification genes were rescued to varying degrees in 4-cell stage SCNT embryos, and the effect was greater at the blastocyst stage after MM-102 treatment. IF staining results of several representative epigenetic modifications also demonstrated this point at the protein level. Our study showed that MM-102 could rescued the abnormal expression patterns of epigenetic modification enzymes during porcine SCNT embryo development, and these findings might reveal the potential mechanism of crosstalk among various epigenetic modifications.
During the regulation of epigenetic modification processes, DNA and histone modification interact with each other. Their relationship is mediated by biochemical interactions of SET domains that each methyltransferase has in common [36] . A previous study showed that increases in global H3K4me3 levels were accompanied by increases in DNA 5hmC levels in mouse brain tissue [28] , suggesting that the mechanism by which how H3K4me3 couples to DNA 5hmC was contrary to our results. Our results showed that abnormally high expression of DNMT1 in SCNT-4C was rescued by MM-102 treatment to a relatively lower level. The down-regulation of global DNA methylation was also confirmed by IF staining of 5mC/5hmC at 4-cell stage. Our results showed a positive correlation between H3K4 methylation and DNA methylation. The reduction of global genome DNA methylation level certainly would contribute to the activation of zygotic genes and cellular reprogramming. We speculated that the difference in this mechanism might be tissue specific. However, the potential mechanisms of crosstalk between DNA methylation and histone methylation had not been thoroughly studied so far; our study might provide a new approach to reveal the mechanism from the perspective of the expression of various epigenetically modified enzymes.
The inhibitors of epigenetic modification could improve not only epigenetic reprogramming but also embryo developmental capacity during SCNT. The expression of pluripotency genes is crucial for the development of preimplantation embryos, but SCNT embryos usually have defects in this respect that limits reprogramming efficiency [37, 38] _ENREF_42. LAQ824, a HDAC inhibitor, could improve porcine SCNT embryos development by increasing levels of H3K9 and H4K12, decreasing the level of 5mC, and positively regulating the expression patterns of genes related to pluripotency and apoptosis [39] . In our study, MM-102 treatment significantly improved developmental rates at each stage and the total number of blastocyst cells. Our results showed that POU5F1 and NANOG were significantly lower in SCNT embryos than in IVV embryos, particularly at the 4-cell stage, but MM-102 treatment partially rescued their expression from the 4-cell to the blastocyst stage. It is reported that disturbing the MLL1-WDR5 interaction might induce apoptosis in leukaemia cells [40] . However, the number of apoptotic cells and the expression of the apoptotic gene BAX were decreased, to some extent, in blastocysts after MM-102 treatment. Our results indicated that MM-102 could greatly improve the quality of blastocysts and SCNT efficiency through increasing the expression of key pluripotent genes and reducing apoptosis.
Conclusion
Our study demonstrates that the reduction of abnormal high H3K4me3 levels by MM-102 not only rescued aberrant gene expression patterns of global epigenetic chromatin modification enzymes during porcine SCNT-mediated reprogramming, but also greatly improved SCNT efficiency and the quality of blastocysts, making them more similar to in vivo embryos.
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